We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Radial Access in Coronary Interventions Reduces Risk

By HospiMedica International staff writers
Posted on 12 Jul 2016
Researchers at the Humanitas Clinical and Research Center (Humanitas; Rozzano, Italy), Bern University Hospital (Switzerland), and other institutions searched PubMed, Embase, the Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov databases for randomized trials comparing radial and femoral access for coronary interventions. More...
In all, 24 studies enrolling 22,843 participants were included in order to provide a quantitative appraisal of t clinical outcomes when comparing access for coronary interventions in patients with CAD.

The results showed that compared to femoral access, radial access was associated with a significantly lower risk for all-cause mortality, major adverse cardiovascular events (MACE), major bleeding, and major vascular complications. The rates of myocardial infarction (MI) or stroke were similar in the two groups. The effects of radial access were consistent across the whole spectrum of patients with CAD and for all appraised endpoints. The study was published on June 29, 2016, in JACC Cardiovascular Interventions.

“Overall, radial access was associated with a 29% relative risk reduction in all-cause mortality and a 16% relative risk reduction in MACE, compared with femoral access,” concluded lead author Giuseppe Ferrante, MD, PhD, of Humanitas, and colleagues. “The mechanism by which radial access is associated with reduced all-cause mortality, compared to femoral access, specifically whether this involves a reduction in the risk of major bleeding, requires additional studies.”

“Radial access is a newer procedure and it involves a longer learning curve to develop the technical skills necessary. However, as radial access is increasingly adopted, benefits seen in trials have been weighed against the learning curve necessary for some operators,” commented Spencer King, MD, editor-in-chief of JACC Cardiovascular Interventions. “This most complete analysis of the value of radial access may convince some doubters to switch.”

Related Links:
Humanitas Clinical and Research Center
Bern University Hospital

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.